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Abstract
AIM
To examine the associations between mental disorders 
and infectious, atopic, inflammatory diseases while 
adjusting for other risk factors.
METHODS
We used data from PsyCoLaus, a large Swiss Population 
Cohort Study (n  = 3720; age range 35-66). Lifetime 
diagnoses of mental disorders were grouped into the 
following categories: Neurodevelopmental, anxiety 
(early and late onset), mood and substance disorders. 
They were regressed on infectious, atopic and other 
inflammatory diseases adjusting for sex, educational 
level, familial aggregation, childhood adversities and 
traumatic experiences in childhood. A multivariate 
logistic regression was applied to each group of 
disorders. In a complementary analysis interactions with 
sex were introduced via  nested effects. 
RESULTS
Associations with infectious, atopic and other chronic 
inflammatory diseases were observable together with 
consistent effects of childhood adversities and familial 
aggregation, and less consistent effects of trauma in 
each group of mental disorders. Streptococcal infections 
were associated with neurodevelopmental disorders 
(men), and measles/mumps/rubella-infections with 
early and late anxiety disorders (women). Gastric inflam-
matory diseases took effect in mood disorders (both 
sexes) and in early disorders (men). Similarly, irritable 
bowel syndrome was prominent in a sex-specific way 
in mood disorders in women, and, moreover, was 
associated with early and late anxiety disorders. Atopic 
diseases were associated with late anxiety disorders. 
Acne (associations with mood disorders in men) and 
psoriasis (associations with early anxiety disorders 
in men and mood disorders in women) contributed 
sex-specific results. Urinary tract infections were 
associated with mood disorders and, in addition, in 
a sex-specific way with late anxiety disorders (men), 
and neurodevelopmental and early anxiety disorders 
(women).
CONCLUSION
Infectious, atopic and inflammatory diseases are 
important risk factors for all groups of mental dis-
orders. The sexual dimorphism of the associations is 
pronounced.
Key words: Neurodevelopmental disorders; Mental 
disorders; Substance abuse; Childhood diseases; 
Infectious diseases; Atopic diseases; Chronic inflam-
matory diseases; Risk factors
© The Author(s) 2016. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: This study adds to the evidence that infectious, 
atopic and inflammatory diseases make up an important 
group of risk factors for neurodevelopmental and 
common mental disorders. They contribute independently 
of further major risk factors such as childhood adversities, 
traumatic experiences and familial aggregation. Each 
group of mental disorders (neurodevelopmental, early 
and late anxiety, mood, substance) attracts different 
combinations of risk factors. The sexual dimorphism 
of the associations is pronounced. The hypothesized 
biological mechanism that acts as a common denominator 
in this group of risk factors involves imbalances, e.g. , 
within the development of the immune system interfering 
with critical stages of brain development. 
Ajdacic-Gross V, Aleksandrowicz A, Rodgers S, Mutsch M, 
Tesic A, Müller M, Kawohl W, Rössler W, Seifritz E, Castelao 
E, Strippoli MPF, Vandeleur C, von Känel R, Paolicelli R, 
Landolt MA, Witthauer C, Lieb R, Preisig M. Infectious, atopic 
and inflammatory diseases, childhood adversities and familial 
aggregation are independently associated with the risk for mental 
disorders: Results from a large Swiss epidemiological study. 
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INTRODUCTION
There is an increasing awareness that infectious dis­
eases, atopies and inflammatory conditions contribute 
to the risk for neurodevelopmental disorders (ND) and 
common mental disorders (CMD). A great number 
of the empirical results documented below underline 
the eminent role of the immune system. Nevertheless 
considerable scepticism abounds. Among other things, it 
is not clear how immunological risk factors are balanced 
against other risk factors in ND and CMD. The main aim 
of this study was, therefore, to assess the associations 
of infectious, atopic and inflammatory diseases with 
ND and CMD while adjusting for socio­demographic 
characteristic, familial aggregation, traumatic experiences 
and childhood adversities. A simple vulnerability­trigger 
model will serve to introduce the state of empirical 
research, thus reducing the potential variability of single 
and multiple hit models to a minimal general form.
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Associations related to triggering mechanisms 
The most intuitive example of a triggering factor in CMD 
is a postinfectious condition such as fatigue[1]. Infectious 
mononucleosis, i.e., typically an Epstein Barr virus (EBV) 
infection in adolescence or adulthood, is a well known 
cause of postinfectious fatigue. However, also several 
other pathogens are also able to upregulate psychiatric 
symptoms, such as persistent pathogens: Borna dis­
ease virus, herpes simplex virus (HSV)­1, varicella 
zoster virus, and Chlamydophila trachomatis[2]. Apart 
from the first attack, a reactivation of an endogenous 
infection can increase the risk of depression[3].
It is noteworthy that the reciprocal causal direction 
also exists[4,5]. Generally speaking, it is not only the 
case that pathogens can trigger psychiatric illness, 
but, conversely, that psychiatric disorders can lead to 
an increased risk of infection. The two should not be 
confounded, keeping in mind that the causal direction 
is not always clear[6]. The examples above illustrate a 
trigger mechanism of ND and CMD, i.e., the second 
part of conventional vulnerability­trigger (or, by analogy, 
diathesis­stress) models. 
Associations related to vulnerability mechanisms 
The first part of the vulnerability­trigger model are 
vulnerability factors occurring very early in life: Infec­
tions, atopic and inflammatory processes that establish, 
apart from their immediate effects, a lasting, possibly 
life­long vulnerability for CMD. A well known example 
of an early vulnerability is comprised in the pediatric 
autoimmune neuropsychiatric disorders associated 
with streptococcal infections (PANDAS) model. This 
model has been applied in attention deficit hyperactivity 
disorder (ADHD), obsessive­compulsive disorder (OCD), 
and tic disorders such as the Gilles de la Tourette 
Syndrome[7,8]. It suggests that some persons with ND 
or CMD might actually suffer from an autoimmune 
disorder due to autoantibodies directed against basal 
ganglia tissue and appearing after infections with group 
A streptococci. 
Evidence for associations between early infections 
and ND and CMD goes far beyond PANDAS and 
other autoimmune processes such as NMDA receptor 
encephalitis[9]. A compelling example is the link bet­
ween EBV infections in childhood and risk of psycho­
tic experiences in adolescence demonstrated in the 
ALSPAC cohort[10]. In a similar vein, studies from the 
Goodwin group which suggested that respiratory dis­
eases in childhood and severe infections requiring the 
use of antibiotics in the first year of life increase the risk 
for several mental disorders such as depression, anxiety 
disorders and oppositional defiant disorder (ODD) later 
on in life[11,12]. 
The temporal sequence between pathogens and CMD 
may apply later in life as well. For instance, Danish record 
linkage studies have shown that individuals hospitalized 
because of an infection, particularly a bacterial infection, 
were more likely to develop schizophrenia later in 
life[13]. Apart from studies demonstrating a temporal 
sequence, many cross­sectional antibody based studies 
have pointed at associations between ND and CMD 
and selected pathogens. Serological studies have 
been particularly proliferative in psychosis research 
by implicating a broad spectrum of viral, bacterial and 
protozoan pathogens. For illustrative purposes, these 
are: (1) herpes viridae (cytomegalovirus[14], human 
herpesvirus­6[15], HSV­1[16,17], EBV[18]); (2) Toxoplasma 
gondii[14,19­23]; (3) Chlamydia infections: trachomatis[23,24], 
psittaci and pneumoniae[25,26]; (4) Mycoplasma 
pneumoniae (case study)[27]; (5) Helicobacter pylori[28]; 
and (6) gastrointestinal pathogens[29,30]. 
Associations related to parallel mechanisms 
Not only were pathogens shown to precede psychotic 
experiences but also atopic diseases such as asthma 
and atopic dermatitis[31]. Similarly, the first occurrence 
of atopic dermatitis was reported to precede major 
depressive disorder and anxiety disorders[32] or 
ADHD[33]. Also other atopic diseases preceded ADHD[34]. 
However, evidence for the converse temporal sequence 
between atopic diseases and ND and CMD was also 
found with ND and CMD occuring first[35,36].
Again, the number of cross­sectional comorbidity 
studies providing evidence for a simple link between ND 
and CMD on the one hand and atopic diseases on the 
other is much greater than those focusing on temporal 
succession. They involve in particular asthma[37­44], hay 
fever[45], and eczema[46]. The association between atopic 
dermatitis and ADHD has gained particular attention 
since it emerges typically in the first years of life[33,47,48]. 
Beside atopies, chronic or relapsing inflammatory 
diseases have been shown to be linked to a great 
variety of CMD, and both theoretically qualify as triggers 
and as vulnerability markers. Skin diseases such as 
acne[49,50], psoriasis[51] and rosaceae[52] also contribute 
to the list of associations. Moreover, this list includes 
gastric inflammatory diseases[53­56], and gastrointestinal 
diseases/syndromes: Irritable bowel syndrome[57,58], 
Crohn’s disease[59], interstitial cystistis[60,61] as well as 
recurrent cystitis[62], autoimmune diseases[63­65] and 
others[51]. This is only a small selection of associations, 
and the list could be extended with ease. 
Aims of the analysis
To summarize, the complex picture of associations 
entails any variant of temporal sequences and almost 
any combination between groups of somatic diseases 
and groups of ND and CMD. Thus, in so far as infectious, 
atopic and chronic inflammatory diseases precede ND 
and CMD or share a mutual vulnerability with them, 
the relevant mechanisms cannot be determined on the 
level of single pathogens. Taken together, the literature 
provides important pieces of a larger puzzle with, 
however, still blurred contours. Comprehensive analyses 
enabling a broader understanding of these links are 
still missing. The present study takes advantage of a 
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disorders) were not included in the analyses. 
Assessment of infectious, atopic and inflammatory 
diseases 
The information on infectious diseases and related 
conditions was derived using an extended version of the 
medical history parts of the DIGS and the SADS­L and 
was based on self­reporting. In the interview participants 
were asked questions about ever having been diagnosed 
with various infectious diseases, diseases of the nervous 
system, cardiovascular, respiratory, gastrointestinal, 
metabolic and dermatological conditions as well as 
allergies and hormonal problems. For each disease, a 
screening question was asked and followed up in the 
case of an affirmative response.
In the current analyses the infectious diseases and 
related conditions were selected: (1) diseases typically 
related to streptococcal infections of the respiratory 
tract (scarlet fever, tonsillitis, rheumatic fever); (2) 
measles/mumps/rubella (MMR); the age range of the 
sample implies that most participants had not received 
an MMR vaccine in childhood, as routine measles and 
later MMR vaccinations schedules were only introduced 
by the Swiss government only in the 1960s; (3) urinary 
tract infections (UTIs) (cystitis, pyelitis, pyelonephritis, 
other nephritis, urethritis, prostatitis); (4) irritable bowel 
syndrome; (5) peptic ulcer/gastritis; (6) asthma and 
atopic diseases; (7) acne; and (8) psoriasis.
Covariates
We adjusted the analysis for the following variables 
which might account for the relationship between 
infectious diseases and mental disorders: (1) sex; (2) 
education level (low: Basic school and apprenticeship 
level; medium: Pre­university and high­level technical 
schools; high: University); (3) familial aggregation 
assessed by the semi­structured Family History ­ 
Research Diagnostic Criteria[74,75] which includes informa­
tion on first and second degree relatives; subtypes 
parallelized to the groups of mental disorders mentioned 
above; dichotomized into any vs none; (4) childhood 
adversities dichotomized into any vs none if one of the 
following questions was confirmed: Did your parents 
fight frequently amongst themselves (interparental 
violence)?; Did your parents ever do anything that 
frightened you (like lock you in a closet)? (fear of 
maltreatment by parents); Did any of the following 
occur before your 16th birthday: .... put in foster care? 
(foster care); Overall, how would you characterize 
your childhood (N/A, happy, either happy not unhappy, 
unhappy, very unhappy)? categorized as yes, if unhappy 
or very unhappy (unhappy children); and (5) traumatic 
experiences in childhood below the age of 10 (serious 
accident or disaster, victim of violent attacks (self or 
loved ones), witnessed homicide or other forms of 
violent deaths; the age limit was chosen in order to 
focus on experiences mostly generating a vulnerability 
for mental disorders instead of acting as a trigger 
large epidemiological data base from the PsyCoLaus 
study[66] to further investigate whether major groups 
of infectious, atopic and inflammatory diseases are 
associated with major groups of mental disorders. 
MATERIALS AND METHODS
The Colaus/PsyCoLaus study
The data used in this analysis stem from CoLaus/
PsyCoLaus[66,67], a cohort study designed to study 
mental disorders and cardio­vascular risk factors in 
the community and to determine their associations.
The sample was randomly selected from the residents 
of the city of Lausanne (Switzerland) from 2003 
to 2006 according to the civil register. Sixty­seven 
percent of the 35 to 66 years old participants of the 
physical baseline exam (n = 5535) also accepted the 
psychiatric evaluation, which resulted in a sample of 
3720 individuals who underwent both the somatic and 
psychiatric exams. 
Measures
A French version of the semi­structured Diagnostic 
Interview for Genetic Studies (DIGS)[68] was used in the 
PsyCoLaus study to assess a broad spectrum of lifetime 
DSM­IV Axis I criteria. The French version has shown 
excellent inter­rater and adequate test­retest reliability 
for major mood and psychotic disorders[69] as well as for 
substance use disorders[70]. Moreover, the DIGS allowed 
for gathering additional information on the course 
and chronology of comorbid features[66]. However, 
the brief phobia section of the DIGS was replaced 
by the corresponding sections from the Schedule for 
Affective Disorders and Schizophrenia ­ Lifetime Version 
(SADS­L)[71] in the current study. The anxiety sections 
of the French version of the SADS­L also revealed 
satisfactory reliability[72]. All diagnoses were lifetime 
diagnoses.
Grouping of mental disorders
We considered the following major groups of mental 
disorders based on the typical age of onset and common 
classifications: (1) neurodevelopmental diseases 
[typically starting during childhood: Tic disorders, 
ADHD, conduct disorder (CD), ODD]; (2) early­onset 
anxiety disorders (typically starting during childhood: 
separation anxiety disorder, overanxious disorder, animal 
phobias, social phobia); (3) late­onset anxiety disorders 
[typically starting after adolescence: Generalized anxiety 
disorder (GAD), panic, agoraphobia, specific phobias 
(excl. animal phobias[73])]; (4) mood disorders (typically 
starting after adolescence: major depressive disorder, 
dysthymia, bipolar disorders); and (5) substance use 
disorders (typically starting after adolescence: alcohol, 
cannabis, other illicit drug abuse/dependence).
Disorders with low frequencies (schizophrenia, 
schizoaffective disorders) or inadequately fitting in with 
the major groups (OCD, personality disorders, eating 
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themselves); the questions were taken from the French 
version of the SADS­LA (see above) and dichotomized 
into any vs none.
Statistical analysis
The data were analyzed using binary logistic regression 
and displaying odds ratios (OR) and 95%CI. The 
regression analysis was redone for men and women 
separately before including interaction effects. In order 
to better figure out the source of sex­specific diver­
gences ­ either men or women ­ the interaction effects 
were modeled via nested effects, i.e., by nesting each 
infectious, atopic and inflammatory variable in men 
and in women. All analyses were carried out using SAS 
version 9.3. The statistical analysis was reviewed by 
Viktor von Wyl from the Epidemiology, Biostatistics and 
Prevention Institute of the University of Zürich.
RESULTS
Table 1 shows the overall and sex­specific prevalence 
estimates for five major groups of mental disorders 
(neurodevelopmental, early­onset anxiety, late­onset 
anxiety, mood and substance disorders) together with 
education level, familial aggregation, trauma below the 
age of 10, childhood adversities and various infectious 
and atopic/inflammatory diseases. In bivariate analyses, 
mental disorders were consistently associated with 
familial aggregation, trauma and childhood adversities. 
Trauma showed distinct sex-specific associations in early 
disorders and in substance abuse. The associations of 
ND and CMD with infectious, atopic and inflammatory 
diseases spread across the whole table in a less 
consistent way. Moreover, they displayed more sex­
specific divergencies. Therefore, and since some 
variables, e.g., UTI, are skewed by sex, an additional 
look at the sex­specific associations was necessary in 
multivariate analyses.
In multivariate analysis (Table 2), the associations 
with familial aggregation and childhood adversities 
remained relatively stable across all five models for 
each group of mental disorders (ORs up to 3). The 
effect of trauma clearly diminished. Each group of ND 
/CMD displayed associations with any of the infectious, 
atopic and inflammatory diseases included in the 
analysis. Many associations occurred at trend level, 
thus suggesting more in­depth analyses either related 
to sex­specific associations or to the level of specific 
disorders. 
Analyses involving interaction effects by nesting 
infectious, atopic and inflammatory diseases within sex 
(Table 3) uncovered further hetereogenity. In detail, ND 
disorders were associated with streptococcal infections 
specifically in men (OR = 1.98, 95%CI: 1.08-3.66) but 
not in women. Peptic ulcer/gastritis was significant only 
in the men model (OR = 1.95, 95%CI: 1.08­3.53), 
and showed a similar tendency in women. The opposite 
applies for UTI, where only women (OR = 1.68, 95%CI: 
1.11­2.54) reached the conventional significance level. 
Early­onset anxiety disorders showed associations 
with MMR, which were similar in both groups; again 
only women (OR = 1.46, 95%CI: 1.01­2.10) reached 
the conventional significance level. Another shared 
issue is irritable bowel syndrome with a strong impact in 
men (OR = 3.15, 95%CI: 1.58­6.28) and a trend level 
impact in women. Associations found specifically in men 
comprise peptic ulcer/gastritis (OR = 1.85, 95%CI: 
1.13­3.05), psoriasis (OR = 2.02, 95%CI: 1.20­3.39) 
and, at trend level, acne. Moreover, associations with 
UTI emerged specifically in women (OR = 1.44, 95%CI: 
1.16­1.79), at trend level also with atopic disease, but 
not in men. 
In late­onset anxiety disorders, UTI (OR = 2.13, 
95%CI: 1.19­3.82) were predictive not in women but 
in men. The significant predictors in women comprise 
MMR (OR = 1.81, 95%CI: 1.12­2.90) and peptic ulcer/
gastritis (OR = 1.60, 95%CI: 1.02­2.51), whereas 
irritable bowel syndrome and atopic disease remain 
significant at the trend level.
Mood disorders were associated with UTI in women 
(OR = 1.47, 95%CI: 1.19­1.81) and in men (OR = 
1.63, 95%CI: 1.00­2.65). Also the impact of peptic 
ulcer/gastritis is apparent in both groups (in women: 
OR = 1.58, 95%CI: 1.02­2.46, and in men: OR = 1.98, 
95%CI: 1.26­3.09). Acne (1.96, 95%CI: 1.35­2.85) 
predicts mood disorders in men, whereas irritable 
bowel syndrome (OR = 2.25, 95%CI: 1.35­3.76) and 
psoriasis (OR = 2.02, 95%CI: 1.14­3.58) contribute in 
women. 
Finally, substance abuse/dependence did not yield 
any relevant associations in women. In men, it was 
linked with peptic ulcer/gastritis (OR = 1.88, 95%CI: 
1.18­2.99) and with acne (OR = 1.74, 95%CI: 
1.17­2.59).
As a side effect of the analysis involving interaction 
effects, the sex main effect in early and late anxiety 
disorders disappeared and greatly diminished in mood 
disorders. The models proved to be stable even when 
the strongest predictors in each model were omitted. 
Preliminary analyses on a more detailed level focusing 
on specific ND and CMD revealed a heterogeneity of 
results that clearly surpassed the findings presented in 
this study (results not shown). 
DISCUSSION
This is the first study to apply a comprehensive epide-
miological perspective on the associations of major 
groups of ND and CMD with infectious, atopic and 
inflammatory diseases. It adds to the evidence that 
infectious, atopic and inflammatory diseases make up an 
important group of risk factors. The main outcome was 
the great range of associations although the statistical 
models had been adjusted for trauma, childhood 
adversities, familial aggregation and education. Provided 
that the analyses were carried out on grouped CMD 
and somatic diseases, the results reported in this 
study represent only the tip of an iceberg. In addition, 
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Ajdacic-Gross V et al . Infectious, atopic and inflammatory diseases: Associations with mental disorders
many associations were sex­specific. Intriguingly, 
accounting for interaction effects of infectious, atopic 
and inflammatory diseases with sex had different 
consequences for ND and CMD. In early and late anxiety 
disorders the sex main effect came down to one, 
meaning that the sex ratio in these disorders was fully 
determined by sex-specific associations with these risk 
factors. 
Challenges 
In view of the broad spectrum of results, the discussion 
will not focus on particular pathogens or findings as was 
done in the introduction, but will attempt to systematize 
them. Their interpretation encounters several basic 
challenges. First, the general heterogeneity of the 
associations between ND/CMD and infectious/atopic/
chronic inflammatory diseses is enormous. The extent 
425 December 22, 2016|Volume 6|Issue 4|WJP|www.wjgnet.com
Model 1 
Neurodevelopmenta­l 
disorders
Model 2
Ea­rly a­nxiety disorders 
Model 3
La­te a­nxiety disorders 
Model 4
Mood disorders 
Model 5
Substa­nce a­buse/ 
dependence
  Sex 0.38 (0.27-0.52) 1.60 (1.33-1.94) 1.50 (1.19-1.87) 2.05 (1.74-2.41) 0.19 (0.14-0.24)
  Education level 
     Low 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
     Medium 0.91 (0.66-1.24) 1.24 (1.01-1.52) 1.11 (0.87-1.41) 0.86 (0.72-1.04) 1.19 (0.92-1.54)
     High 1.10 (0.78-1.56) 1.08 (0.87-1.34) 1.07 (0.83-1.39) 0.88 (0.72-1.06) 1.27 (0.98-1.66)
  Familial aggregation of CMD 1.55 (1.07-2.23) 2.54 (2.14-3.01) 1.75 (1.34-2.29) 1.77 (1.52-2.06) 2.12 (1.59-2.82)
  Trauma below age of 10 1.43 (0.84-2.44) 1.07 (0.73-1.57) 1.12 (0.73-1.71) 1.11 (0.76-1.62) 1.36 (0.84-2.20)
  Childhood adversities 2.74 (2.09-3.60) 1.51 (1.25-1.81) 1.89 (1.53-2.33) 1.87 (1.57-2.23) 1.81 (1.45-2.27)
  Streptococcal infections 1.29 (0.79-2.10) 1.11 (0.80-1.55) 1.22 (0.84-1.78) 0.80 (0.59-1.10) 0.80 (0.51-1.25)
  Mumps, measles, rubella 1.37 (0.91-2.06) 1.36 (1.04-1.77) 1.33 (0.97-1.83) 1.07 (0.86-1.34) 1.15 (0.85-1.54)
  Peptic ulcer/gastritis 1.72 (1.11-2.68) 1.23 (0.89-1.71) 1.47 (1.03-2.11) 1.74 (1.27-2.39) 1.58 (1.09-2.29)
  Irritable bowel syndrome 1.30 (0.71-2.36) 1.81 (1.24-2.64) 1.74 (1.15-2.62) 1.87 (1.26-2.79) 1.70 (1.06-2.73)
  Atopic diseases 0.95 (0.73-1.25) 1.11 (0.94-1.31) 1.24 (1.01-1.51) 1.06 (0.91-1.24) 1.02 (0.83-1.26)
  Acne 0.83 (0.53-1.30) 1.10 (0.85-1.43) 1.02 (0.74-1.39) 1.23 (0.97-1.57) 1.27 (0.92-1.76)
  Psoriasis 1.22 (0.69-2.16) 1.45 (0.99-2.11) 1.05 (0.66-1.69) 1.59 (1.11-2.28) 1.41 (0.91-2.19)
  Urinary tract infections 1.51 (1.06-2.14) 1.37 (1.12-1.67) 1.06 (0.83-1.35) 1.49 (1.22-1.80) 1.20 (0.88-1.64)
Table 2  Mental disorders regressed on infectious, atopic and inflammatory diseases, odds-ratios and 95%CI derived from logistic 
regression models 
CMD: Common mental disorders.
Model 1 
Neurodevelopmenta­l 
disorders
Model 2
Ea­rly a­nxiety 
disorders 
Model 3
La­te a­nxiety 
disorders 
Model 4
Mood disorders 
Model 5
Substa­nce a­buse/ 
dependence 
  Sex 0.41 (0.23-0.72) 0.79 (0.54-1.15) 1.08 (0.68-1.69) 1.56 (1.08-2.26) 0.34 (0.21-0.54)
  Education level 
     Low 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
     Medium 1.09 (0.79-1.49) 0.79 (0.65-0.98) 0.89 (0.70-1.13) 1.15 (0.96-1.38) 0.83 (0.64-1.08)
     High 0.88 (0.62-1.25) 0.91 (0.73-1.14) 0.92 (0.71-1.20) 1.12 (0.92-1.36) 0.77 (0.59-1.01)
  Familial aggregation of 
  CMD 
1.53 (1.06-2.21) 2.53 (2.14-3.00) 1.78 (1.36-2.33) 1.77 (1.52-2.06) 2.14 (1.60-2.86)
  Trauma below age of 10 1.47 (0.86-2.50) 1.08 (0.73-1.58) 1.11 (0.73-1.71) 1.12 (0.76-1.64) 1.40 (0.86-2.27)
  Childhood adversities 2.78 (2.12-3.65) 1.52 (1.26-1.83) 1.91 (1.55-2.36) 1.89 (1.59-2.25) 1.83 (1.46-2.29)
  Streptococcal infections Women nested 0.69 (0.29-1.67) 1.15 (0.76-1.73) 1.32 (0.84-2.07) 0.91 (0.60-1.36) 0.87 (0.42-1.82)
Men nested 1.98 (1.08-3.66) 1.08 (0.60-1.92) 1.04 (0.51-2.09) 0.67 (0.40-1.12) 0.78 (0.44-1.39)
  Mumps, measles, rubella Women nested 1.16 (0.58-2.32) 1.46 (1.01-2.10) 1.81 (1.12-2.90) 0.97 (0.70-1.35) 1.62 (0.79-3.29)
Men nested 1.47 (0.88-2.45) 1.29 (0.88-1.91) 0.96 (0.62-1.49) 1.12 (0.83-1.52) 1.04 (0.74-1.46)
  Peptic ulcer/gastritis Women nested 1.72 (0.88-3.34) 0.97 (0.63-1.49) 1.60 (1.02-2.51) 1.58 (1.02-2.46) 1.19 (0.61-2.35)
Men nested 1.95 (1.08-3.53) 1.85 (1.13-3.05) 1.25 (0.67-2.35) 1.98 (1.26-3.09) 1.88 (1.18-2.99)
  Irritable bowel syndrome Women nested 1.23 (0.56-2.70) 1.48 (0.95-2.30) 1.60 (0.99-2.57) 2.25 (1.35-3.76) 1.63 (0.84-3.16)
Men nested 1.74 (0.70-4.36) 3.15 (1.58-6.28) 1.97 (0.86-2.48) 1.33 (0.67-2.62) 1.80 (0.90-3.61)
  Atopic diseases Women nested 0.74 (0.48-1.12) 1.19 (0.96-1.47) 1.28 (0.99-1.66) 0.97 (0.79-1.18) 1.02 (0.69-1.49)
Men nested 1.14 (0.80-1.61) 1.02 (0.77-1.34) 1.19 (0.86-1.66) 1.22 (0.97-1.53) 1.05 (0.81-1.35)
  Acne Women nested 0.75 (0.39-1.47) 0.94 (0.68-1.31) 0.82 (0.55-1.23) 0.90 (0.66-1.24) 0.74 (0.40-1.37)
Men nested 0.92 (0.50-1.67) 1.47 (0.96-2.25) 1.52 (0.92-2.51) 1.96 (1.35-2.85) 1.74 (1.17-2.59)
  Psoriasis Women nested 0.84 (0.29-2.43) 1.05 (0.60-1.82) 1.48 (0.83-2.66) 2.02 (1.14-3.58) 1.70 (0.77-3.73)
Men nested 1.44 (0.73-2.86) 2.02 (1.20-3.39) 0.60 (0.25-1.42) 1.33 (0.82-2.17) 1.30 (0.76-2.21)
  Urinary tract infections Women nested 1.68 (1.11-2.54) 1.44 (1.16-1.79) 0.94 (0.72-1.22) 1.47 (1.19-1.81) 1.30 (0.89-1.89)
Men nested 1.26 (0.63-2.51) 0.99 (0.55-1.76) 2.13 (1.19-3.82) 1.63 (1.00-2.65) 1.04 (0.61-1.79)
Table 3  Mental disorders regressed on infectious, atopic and inflammatory diseases, odds-ratios and 95%CIs derived from logistic 
regression models with nested effects 
CMD: Common mental disorders.
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and heterogeneity of associations require appropriate, 
i.e., neither universal nor parsimonious explanatory 
approaches. This methodological argument also 
applies also for the surprising sexual dimorphism of 
associations between ND/CMD and infectious, atopic 
and inflammatory diseases: There must be several 
mechanisms inducing sex­specific differences in rates 
of ND/CMD. Not least, this also applies to the different 
ages when CMD risk factors may emerge. While much 
attention has been paid to prenatal and perinatal 
events[76­78], the impact of MMR or scarlet fever in the 
current results shows that the age range can vary 
broadly. In brief: The same infectious disease or immune 
system imbalance could yield different vulnerability 
outcomes, depending on the age when it occurs. 
Interpretation approaches 
On a formal level the interpretation of the findings can 
follow three basic pathways (see, for example)[47]: (1) 
infectious, atopic and inflammatory diseases induce a 
risk for ND and CMD; (2) ND and CMD increase the risk 
for infectious, atopic and inflammatory diseases; and (3) 
both ND/CMD and infectious, atopic and inflammatory 
diseases share the same intermediate mechanisms or 
etiopathogenetic processes. These pathways will be 
used in the following to categorize and interpret the 
results. 
Most of the current results point to the pathways 
one and three. In instances such as childhood infectious 
diseases the interpretation seems to be relatively 
unambiguous. Childhood infections lend themselves 
to the first pathway since they mostly precede other 
disorders or diseases. The range of potentially relevant 
pathogens, that figure as risk factors for mental dis­
orders extends beyond well investigated prenatal 
infections (in the first place those summarized under the 
label TORCH ­ toxoplasmosis, rubella, cytomegalovirus, 
herpes)[79,80] and the PANDAS model (related to group 
A streptococcal infections in early childhood)[81]. In the 
current analysis it includes viral pathogens (MMR) in 
addition to streptococcal diseases. Moreover, the brief 
list of infectious diseases involved is to be understood 
as a preliminary compilation. More specific analyses, 
for example on anxiety disorders[82], would contribute 
additional links. In addition, several frequently occurring 
infectious agents in childhood cannot be adequately 
assessed by self­report data (e.g., Haemophilus 
influenzae, respiratory syncytial virus, influenza). 
Similar reasoning about the sequence of events also 
applies to atopic diseases. They often start in childhood 
and adolescence, i.e., mostly before mood disorders 
(men) and late anxiety disorders (women). Thus, 
atopic diseases also seem to contribute to CMD rather 
than the other way round. However, atopic diseases 
represent a different type of immune system imbalance 
than infectious childhood diseases. It is a puzzling 
finding that the same disorder can be associated with 
risk factors which represent different, partly even 
antagonistic or competing immune system responses, 
such as Th1 vs Th2 or Th17 vs Treg[83]. 
This phenomenon can be perceived in associations 
related to chronic inflammatory diseases which 
represent pathway 3 above. For example, acne[84] and 
psoriasis[85] are assumed to be Th1/17 related skin 
diseases, whereas atopic eczema or the irritable bowel 
syndrome[57] are considered to have mainly[86] a Th2 
related background. 
Pathways 1 and 3 suggest that immunological pro­
cesses are the common denominator of the related 
risk factors of ND/CMD. The immunological hypothesis 
in ND and CMD has many direct contributors, such 
as the TORCH (Toxoplasma gondii, rubella virus, 
cytomegalovirus, and herpes simplex virus)[80] and 
PANDAS models in ND disorders, serological studies, 
for example in schizophrenia (see above), leucocyte 
counts in depression[87], gastrointestinal inflammation in 
psychosis[29], the autoantibodies link[88], the inflammation 
topic in mood disorders[89], and, finally, evidence for 
upregulated proinflammatory mediators such as IL-1β, 
IL­6 and TNF­a[90]. However, in some instances such as 
UTI or ulcer the categorization of immune processes is 
less clear and may involve different basic mechanisms. 
Hypotheses regarding the neurophysiological 
background mechanisms 
The basic assumption of the immunological hypothesis 
within a two or three hit model (i.e., a vulnerability­
trigger model) of CMD is that immune system imba­
lances impact brain development during critical stages. 
Animal models referring to neonates have shown 
that bacterial infections may have an impact both on 
brain development and on the programming of the 
immune system[91­93]. While this research is based 
on E. coli models, the implications might generalize 
to other microbes, including streptococci, as well. It 
has been suggested that this pathway relies on the 
impact of cytokines on microglia, which in turn crucially 
influence brain development at different stages of life 
by influencing cell proliferation, synaptogenesis and 
immune processes in exchange with astrocytes, neurons 
and oligodendroglia[94,95]. An interesting perspective 
that has emerged recently is that mast cells are able to 
activate microglia[96]. 
In agreement with epidemiological research, the 
microglia pathway offers new perspectives for the 
understanding of the sex­ratios in mental disorders. 
Microglia numbers in males and females are differently 
skewed at different age stages. In early childhood, more 
microglia can be discerned in various brain regions of 
males, whereas in adolescence and adulthood, there 
are more microglia in the brains of females[97]. If more 
frequent, microglia are at the same time more “active”[94]. 
Limitations
While the promise of this study relies on a compre­
hensive epidemiological approach not feasible in most 
other subdisciplines in psychiatry, the study also has 
several limitations. First, all information is based on 
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the self­reporting of study subjects, which implies a 
substantial recall bias, both regarding mental problems 
and infectious diseases. Provided that infectious 
diseases remain asymptomatic in many instances and 
that underreporting is the most probable biasing effect 
regarding adverse experiences and stigmatized issues, 
our results represent rather conservative approximations 
of the “real” associations. Second, herpes as well as 
measles, mumps and rubella infections were presumably 
reported more frequently by subjects with a more 
severe or an exanthematic appearance of the infection. 
Thus, while these infections were underreported in this 
study, their frequencies implicitly provide a measure of 
disease severity. A similar limitation also applies to UTI 
and streptococcal infections. Third, the age of onset in 
streptococcal infections, herpes infections and in UTI 
could not be reliably assessed, the first two because of 
the inclusion of related diseases and late sequels, the 
latter because of the large proportion of undiagnosed or 
asymptomatic UTI in childhood. Finally, several further 
infectious agents of interest could not be identified by 
self report (see above) and thus could not be considered 
for the analysis.
In conclusion, atopic and inflammatory diseases 
make up an important group of potential risk factors 
for ND and CMD. They contribute independently of 
further major risk factors such as childhood adversities, 
traumatic experiences and familial aggregation. While 
the amount of evidence is enormous and continuously 
growing, the interpretational framework is compromised 
by the fact, that ­ similarly to research on smoking and 
cancer ­ direct experimental proofs are not feasible. 
Meanwhile, prevention in this field might already 
be going on unnoticed due to classical tools such as 
vaccinations and appropriate treatment of infectious 
diseases in childhood[98]. 
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